C

Clinical Research Philadelphia | Philadelphia, PA

Research site
(Unclaimed)
Location
9501 Roosevelt Boulevard, Suit 208, Philadelphia, Pennsylvania, United States of America

Site insights

Top conditions

Top treatments

Amlitelimab
Rimegepant

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 4 total trials

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 1)

This is a parallel group, Phase 3, multinational, multicenter, randomized, double blind, placebo-controlled, 3-arm monotherapy study for treatment of...

Enrolling
Dermatitis Atopic
Drug: Amlitelimab
Drug: Placebo

The purpose of this study is to further evaluate the long-term safety and tolerability of daily dosing of rimegepant for the prevention of episodic m...

Active, not recruiting
Photophobia
Migraine
Drug: Rimegepant

Trial sponsors

Pfizer logo
Allergan logo
Sanofi logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems